Last updated on July 2020

An Induction Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 1)

Brief description of study

The purpose of this study is to evaluate the safety and efficacy of Mirikizumab in participants with moderately to severely active ulcerative colitis (UC) who have had an inadequate response to, loss of response, or intolerant to conventional or biologic therapy for UC.

Clinical Study Identifier: NCT03518086

Find a site near you

Start Over

Mediendo s.r.o.

Praha 8 - Karlin, Czechia
  Connect »

ISCARE Clinical Centre

Praha 7, Czechia
  Connect »

ISCARE Clinical Centre

Praha 9, Czechia
  Connect »

Klinika ResTrial

Praha, Czechia
  Connect »

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.